Opti-Joint
Natural health product licensed in Canada
- Licence holder
- BXD Invest & Develop Ltd.
- NPN or DIN-HM
- 80037587
- Status
- Active licence
- Licence date
- 19 November 2012
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Sulfate de glucosamine chlorure de potassium | 375 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Exosquelette de crabe | 375 milligramme | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : exosquelettes de crevettes | 375 milligramme | Not calculated |
| Collagène hydrolysé Source : Os de porcins | 20 milligramme | Not calculated |
| Collagène hydrolysé Source : Collagène hydrolysé | 20 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 4 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain associated with osteoarthritis. Helps to relieve the pain associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
No known report.
- Effets indésirables connus
Some people may experience mild gastrointestinal bloating, constipation or indigestion. Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Nausea, vomiting, and diarrhoea have been known to occur, in which case discontinue.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms worsen. Consult health care practitioner prior to use if you have gastrointestinal lesions/ulcers, are taking anticoagulant agents, anti-inflammatory agents or antibiotics or before having surgery.
Source
Official Health Canada record, licence 80037587
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.